tm logo
KOMIPHARM
Live/Registered
REGISTERED

on 17 Oct 2023

Last Applicant/ Owned by

17, Gyeongje-ro, Siheung-si

Gyeonggi-do

KR

15094

Serial Number

97592514 filed on 15th Sep 2022

Registration Number

7195229 registered on 17th Oct 2023

in the Principal Register

Correspondent Address

Kwang Yup Chae

KWANG YUP CHAE

2318 MILL ROAD

SUITE 1400

ALEXANDRIA, VA 22314

Filing Basis

No Filing Basis

Disclaimer

NO DATA

KOMIPHARM

Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Insecticides; Germicides; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis Read More

Classification Information


Class [005]
Pharmaceutical Products


Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Insecticides; Germicides; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis

Mark Details


Serial Number

No 97592514

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 123027-0327T

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
17th Oct 2023REGISTERED-PRINCIPAL REGISTER
17th Oct 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
01st Aug 2023PUBLISHED FOR OPPOSITION
01st Aug 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Jul 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27th Jun 2023ASSIGNED TO EXAMINER
27th Jun 2023APPROVED FOR PUB - PRINCIPAL REGISTER
29th Sep 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19th Sep 2022NEW APPLICATION ENTERED